BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26432041)

  • 1. Pros and cons of vaginal brachytherapy after external beam radiation therapy in endometrial cancer.
    Mitra D; Klopp AH; Viswanathan AN
    Gynecol Oncol; 2016 Jan; 140(1):167-75. PubMed ID: 26432041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role for vaginal cuff brachytherapy boost after external beam radiation therapy in endometrial cancer.
    Griffith T; Nwachukwu C; Albuquerque K; Gaffney D
    Brachytherapy; 2022; 21(2):177-185. PubMed ID: 35210017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal brachytherapy alone: an alternative to adjuvant whole pelvis radiation for early stage endometrial cancer.
    Jolly S; Vargas C; Kumar T; Weiner S; Brabbins D; Chen P; Floyd W; Martinez AA
    Gynecol Oncol; 2005 Jun; 97(3):887-92. PubMed ID: 15943991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Brachytherapy Task Group Report: Adjuvant vaginal brachytherapy for early-stage endometrial cancer: A comprehensive review.
    Harkenrider MM; Block AM; Alektiar KM; Gaffney DK; Jones E; Klopp A; Viswanathan AN; Small W
    Brachytherapy; 2017; 16(1):95-108. PubMed ID: 27260082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant vaginal brachytherapy alone for high risk localized endometrial cancer as defined by the three major randomized trials of adjuvant pelvic radiation.
    McCloskey SA; Tchabo NE; Malhotra HK; Odunsi K; Rodabaugh K; Singhal P; Lele S; Jaggernauth W
    Gynecol Oncol; 2010 Mar; 116(3):404-7. PubMed ID: 19944453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy.
    Small W; Erickson B; Kwakwa F
    Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1502-7. PubMed ID: 16109462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overuse of external beam radiotherapy for stage I endometrial cancer.
    Wright JD; Margolis B; Hou JY; Burke WM; Tergas AI; Huang Y; Hu JC; Ananth CV; Neugut AI; Hershman DL
    Am J Obstet Gynecol; 2016 Jul; 215(1):75.e1-7. PubMed ID: 26875941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the utilization of adjuvant vaginal brachytherapy in women with early-stage endometrial carcinoma: Results of an updated period analysis of SEER data.
    Modh A; Ghanem AI; Burmeister C; Rasool N; Elshaikh MA
    Brachytherapy; 2016; 15(5):554-61. PubMed ID: 27475480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of vaginal cuff brachytherapy in endometrial cancer.
    Harkenrider MM; Block AM; Siddiqui ZA; Small W
    Gynecol Oncol; 2015 Feb; 136(2):365-72. PubMed ID: 25555710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of vaginal recurrences in endometrial carcinoma by high-dose-rate brachytherapy.
    Sorbe B; Söderström K
    Anticancer Res; 2013 Jan; 33(1):241-7. PubMed ID: 23267151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Postoperative vaginal brachytherapy in endometrial cancer].
    Mazeron R; Khodari W; Gilmore J; Champoudry J; Dumas I; Morice P; Lhommé C; Haie-Méder C
    Bull Cancer; 2012 Jan; 99(1):69-77. PubMed ID: 22231748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal brachytherapy for early stage uterine papillary serous and clear cell endometrial cancer.
    Townamchai K; Berkowitz R; Bhagwat M; Damato AL; Friesen S; Lee LJ; Matulonis U; O'Farrell D; Viswanathan AN
    Gynecol Oncol; 2013 Apr; 129(1):18-21. PubMed ID: 23262378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of concurrent vaginal brachytherapy during chemotherapy for treatment of endometrial cancer.
    Nagar H; Boothe D; Parikh A; Yondorf M; Parashar B; Gupta D; Holcomb K; Caputo T; Chao KS; Nori D; Wernicke AG
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):665-9. PubMed ID: 24138915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: no need for external-beam radiotherapy in low and intermediate risk patients.
    Röper B; Astner ST; Heydemann-Obradovic A; Thamm R; Jacob V; Hölzel D; Schmalfeldt B; Kiechle-Bahat M; Höss C; Molls M
    Gynecol Oncol; 2007 Dec; 107(3):541-8. PubMed ID: 17884152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of vaginal stenosis after intravaginal high-dose-rate brachytherapy for endometrial carcinoma.
    Park HS; Ratner ES; Lucarelli L; Polizzi S; Higgins SA; Damast S
    Brachytherapy; 2015; 14(4):464-70. PubMed ID: 25887343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma--a prospective randomized study.
    Sorbe B; Horvath G; Andersson H; Boman K; Lundgren C; Pettersson B
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1249-55. PubMed ID: 21676554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does adjuvant concurrent or sequential chemotherapy increase the radiation-related toxicity of vaginal brachytherapy for endometrial cancer patients?
    Nieto K; Martin B; Pham N; Palmere L; Silva SR; Winder A; Liotta M; Potkul RK; Small W; Harkenrider MM
    Brachytherapy; 2018; 17(6):929-934. PubMed ID: 30227976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
    Alektiar KM; Venkatraman E; Chi DS; Barakat RR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):111-7. PubMed ID: 15850910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial-Length Treatment With Brachytherapy in Patients With Endometrial Cancer With High-Risk Features Is as Effective as Full-Length Vaginal Brachytherapy but With Reduced Toxicity.
    Wernicke AG; Parashar B; Samuel E; Sabbas A; Gupta D; Caputo T
    Pract Radiat Oncol; 2023; 13(5):e416-e422. PubMed ID: 37295725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Standards, options, and recommendations for the radiotherapy of patients with endometrial cancer. FNCLCC (National Federation of Cancer Campaign Centers) and CRLCC (Regional Cancer Campaign Centers)].
    Thomas L; Bataillard A; Brémond A; Fondrinier E; Fervers B; Achard JL; Lansac J; Bailly C; Hoffstetter S; Basuyau JP; d'Anjou J; Descamps P; Farsi F; Guastalla JP; Laffargue F; Rodier JF; Vincent P; Pigneux J
    Cancer Radiother; 2001 Apr; 5(2):163-92. PubMed ID: 11355582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.